Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Inflammatory Bowel Diseases

Free Subscription 02.09.2024 1 Aliment Pharmacol Ther 1 Am J Gastroenterol 6 Clin Gastroenterol Hepatol 1 Gastroenterology 1 Gut 8 Inflamm Bowel Dis 6 J Crohns Colitis 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Aliment Pharmacol Ther

1. LING LUNDSTROM M, Peterson C, Hedin CRH, Bergemalm D, et al
   Faecal biomarkers for diagnosis and prediction of disease course in treatment-naive patients with IBD.
   Aliment Pharmacol Ther. 2024;60:765-777.
   PubMed         Abstract available
   
   

   
   Am J Gastroenterol

2. KAYAL M, Posner H, Jimenez D, Huang J, et al
   Endoscopic Response Reduces the Risk of Subsequent Pouchitis in Patients with Crohn's Disease Like Pouch Inflammation.
   Am J Gastroenterol. 2024 Aug 27. doi: 10.14309/ajg.0000000000003055.
   PubMed         Abstract available
   
   

   
   Clin Gastroenterol Hepatol

3. MCLAUGHLIN JF, Linville T, Jester TW, Marciano TA, et al
   Travel Time to Treating Center is Associated with Diagnostic Delay in Pediatric Inflammatory Bowel Disease.
   Clin Gastroenterol Hepatol. 2024 Aug 22:S1542-3565(24)00761.
   PubMed         Abstract available
   
   
4. IOANNOU S, Beecham A, Gomez L, Dauer R, et al
   Ancestral diversity in pharmacogenomics affects treatment for Hispanic/Latine populations with inflammatory bowel disease.
   Clin Gastroenterol Hepatol. 2024 Aug 22:S1542-3565(24)00766.
   PubMed         Abstract available
   
   
5. SHEHAB M, Alrashed F, Alsayegh A, Aldallal U, et al
   Comparative Efficacy of Biologics and Small Molecule in Ulcerative Colitis: A Systematic Review and Network Meta-analysis.
   Clin Gastroenterol Hepatol. 2024 Aug 23:S1542-3565(24)00767.
   PubMed         Abstract available
   
   
6. REVES J, Fernandez-Clotet A, Ordas I, Buisson A, et al
   Early biological therapy within 12 months of diagnosis leads to higher transmural healing rates in Crohn's disease.
   Clin Gastroenterol Hepatol. 2024 Aug 27:S1542-3565(24)00769.
   PubMed         Abstract available
   
   
7. GOODSALL TM, An YK, Andrews JM, Begun J, et al
   Reliability of intestinal ultrasound for evaluating Crohn's disease activity using point-of-care and central reading.
   Clin Gastroenterol Hepatol. 2024 Aug 27:S1542-3565(24)00773.
   PubMed         Abstract available
   
   
8. WEWER MD, Letnar G, Andersen KK, Malham M, et al
   Thiopurines and the Risk of Cancer in Patients with Inflammatory Bowel Disease and Reference Individuals without Inflammatory Bowel Disease - A Danish Nationwide Cohort Study (1996-2018).
   Clin Gastroenterol Hepatol. 2024 Aug 27:S1542-3565(24)00772.
   PubMed         Abstract available
   
   

   
   Gastroenterology

9. LEE SH, Turpin W, Espin-Garcia O, Xu W, et al
   Development and Validation of an Integrative Risk Score for Future Risk of Crohn's Disease in Healthy First-Degree Relatives: A Multicentre Prospective Cohort Study.
   Gastroenterology. 2024 Aug 27:S0016-5085(24)05401.
   PubMed        
   
   

   
   Gut

10. ESTEVINHO MM, Midya V, Cohen-Mekelburg S, Allin KH, et al
    Emerging role of environmental pollutants in inflammatory bowel disease risk, outcomes and underlying mechanisms.
    Gut. 2024 Aug 30:gutjnl-2024-332523. doi: 10.1136/gutjnl-2024-332523.
    PubMed         Abstract available
    
    

    
    Inflamm Bowel Dis

11. SOLITANO V, Vuyyuru SK, Aruljothy A, Alkhattabi M, et al
    Endoscopic Skipping, Stricturing, and Penetrating Complications in Crohn's Disease on Tandem Ileo-colonoscopy and Cross-sectional Imaging: A Retrospective Cohort Study.
    Inflamm Bowel Dis. 2024 Aug 31:izae192. doi: 10.1093.
    PubMed         Abstract available
    
    
12. HILLEY P, Wong D, De Cruz P
    How Does an Integrated Pharmacist Add Value in the Management of Inflammatory Bowel Disease in the Era of Values-Based Healthcare?
    Inflamm Bowel Dis. 2024 Aug 29:izae196. doi: 10.1093.
    PubMed         Abstract available
    
    
13. CHAN P, McNamara J, Vernon-Roberts A, Giles EM, et al
    Systematic Review: Practices and Programs in Inflammatory Bowel Disease Transition Care.
    Inflamm Bowel Dis. 2024 Aug 28:izae190. doi: 10.1093.
    PubMed         Abstract available
    
    
14. KANG H, Schmoyer CJ, Weiss A, Lewis JD, et al
    Meta-analysis of the Therapeutic Impact of Cannabinoids in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2024 Aug 28:izae158. doi: 10.1093.
    PubMed         Abstract available
    
    
15. DAMIANOS JA, Osikoya O, Brennan G
    Upadacitinib for Acute Severe Ulcerative Colitis: A Systematic Review.
    Inflamm Bowel Dis. 2024 Aug 26:izae191. doi: 10.1093.
    PubMed         Abstract available
    
    
16. GSENGER V, Rodriguez A, Araka E, Oza F, et al
    A Study of Patient Concerns in the Modern Therapeutic Era of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2024 Aug 27:izae197. doi: 10.1093.
    PubMed         Abstract available
    
    
17. DRAGASEVIC S, Stankovic B, Kotur N, Sokic Milutinovic A, et al
    Psychological Distress Is Associated With Inflammatory Bowel Disease Manifestation and Mucosal Inflammation.
    Inflamm Bowel Dis. 2024 Aug 27:izae180. doi: 10.1093.
    PubMed         Abstract available
    
    
18. JUN YK, Oh HJ, Lee JA, Choi Y, et al
    The Potential of Molecular Remission: Tissue Neutrophil Elastase Is Better Than Histological Activity for Predicting Long-Term Relapse in Patients With Ulcerative Colitis in Endoscopic Remission.
    Inflamm Bowel Dis. 2024 Aug 27:izae194. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Crohns Colitis

19. JURICKOVA I, Dreskin BW, Angerman E, Bonkowski E, et al
    Eicosatetraynoic Acid Regulates Pro-Fibrotic Pathways in an Induced Pluripotent Stem Cell Derived Macrophage:Human Intestinal Organoid Model of Crohn's Disease.
    J Crohns Colitis. 2024 Aug 30:jjae139. doi: 10.1093.
    PubMed         Abstract available
    
    
20. ROTH D, Dull MM, Horst LJ, Lindemann A, et al
    Integrin alphaVss6 - autoantigen and driver of epithelial remodeling in colon and bile ducts in primary sclerosing cholangitis and inflammatory bowel disease.
    J Crohns Colitis. 2024 Aug 30:jjae131. doi: 10.1093.
    PubMed         Abstract available
    
    
21. TEMIDO MJ, Honap S, Danese S, Jairath V, et al
    Nested Randomized Controlled Trials in Large Databases: An Opportunity for Inflammatory Bowel Disease?
    J Crohns Colitis. 2024 Aug 29:jjae136. doi: 10.1093.
    PubMed         Abstract available
    
    
22. NARDONE OM, Calabrese G, Bertin L, Ford AC, et al
    Prevalence of Sexual Dysfunction In Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.
    J Crohns Colitis. 2024 Aug 26:jjae133. doi: 10.1093.
    PubMed         Abstract available
    
    
23. SIEGEL CA, Melmed GY
    Measurement Is Necessary But Not Sufficient to Improve Quality of Care for Patients With Inflammatory Bowel Disease.
    J Crohns Colitis. 2024 Aug 23:jjae119. doi: 10.1093.
    PubMed        
    
    
24. PANACCIONE R, Ma C, Jairath V, Dignass A, et al
    Achievement of Endoscopic Remission After Induction Reduces Hospitalization Burden in Crohn's Disease: Findings From a Pooled Post Hoc Analysis of Risankizumab and Upadacitinib Phase III Trials.
    J Crohns Colitis. 2024 Aug 30:jjae128. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    PLoS One

25. KOSHIBA R, Kakimoto K, Mizuta N, Numa K, et al
    C-reactive protein-to-lymphocyte ratio is a novel biomarker for predicting the long-term efficacy of ustekinumab treatment in ulcerative colitis.
    PLoS One. 2024;19:e0305324.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.